There is no evidence that prescribing cholesterol-lowering statins to patients at risk for, but without, heart disease reduces their chances for early death, according to a meta-analysis.
There is no evidence that prescribing cholesterol-lowering statins to patients at risk for, but without, heart disease reduces their chances of early death, according to the findings of a recent meta-analysis.
British researchers included 11 prospective, randomized, controlled trials of statin therapy in persons free from cardiovascular disease at baseline. They reviewed data on more than 65,000 participants followed for approximately 244,000 person-years, during which time 2,793 deaths occurred, including 1,447 participants using placebo and 1,346 using statins.
The use of statins was not associated with a statistically significant reduction in the risk of all-cause mortality (risk ratio, 0.91; 95% CI, 0.83-1.01). Although low-density lipoprotein cholesterol levels were lower among those participants taking statins than among those taking placebo, this finding did not translate into a reduced risk for premature death.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More